Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter





IVF drugs may reduce breast cancer risk if fertility treatment unsuccessful

23 July 2012

By Victoria Kay

Appeared in BioNews 666

Women who undergo fertility treatment but do not become pregnant have a reduced risk of developing breast cancer before the age of 50, according to scientists.

The research, conducted at the National Institutes of Health in the USA, found the risk was slightly reduced in women treated with ovulation-stimulating fertility drugs. Women who went on to have a pregnancy lasting for ten weeks or longer, however, had a significantly higher risk compared to those for whom treatment was unsuccessful. This increased risk was comparable to that of women who have never received fertility treatment, suggesting that pregnancy reverses the protection provided by the fertility drugs.

'I don't see the results as any cause for alarm. But everyone needs to manage their risk and be careful', lead researcher Dr Clarice Weinberg, from the National Institute of Environmental Health Sciences, said.

Dr Marcelle Cedars, a reproductive endocrinologist from the University of California who was not involved in the study, added: 'Even in the group at an increased risk after their pregnancy, their risk was not higher than the general public. If you use fertility drugs, you're not increasing your risk'.

The researchers followed 1,400 women who had been diagnosed with breast cancer before the age of 50, along with 1,600 of their sisters who had never had breast cancer. Of these women, 288 reported using ovulation-stimulating fertility drugs, with 141 going on to conceive a pregnancy lasting for ten or more weeks. Those who received treatment but did not become pregnant had a significantly reduced risk of young-onset breast cancer compared to those who did go on to conceive.

Ovulation-stimulating drugs increase the production of oestrogen - a hormone that has previously been linked to breast cancer. Oestrogen levels gradually return to normal in women who do not become pregnant, but remain high in those who do and may affect breast tissue remodelling during pregnancy.

Dr Louise Brinton, chief of hormonal reproductive epidemiology at the National Cancer Institute, believes that the choice of fertility drug - most of the women in the study were treated with clomiphene, which belongs to the same family as the chemotherapy drug tamoxifen - explains the reduction in breast cancer risk.

The research is published in the Journal of the National Cancer Institute.

 

SOURCES & REFERENCES
Journal of the National Cancer Institute | 06 July 2012
 
EurekAlert! | 06 July 2012
 
Journal of the National Cancer Institute | 06 July 2012
 
ABC News | 06 July 2012
 
Doctors Lounge | 09 July 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

07 April 2014 - by Dr Lux Fatimathas 
Fertility drugs used to stimulate ovulation did not increase the chances of breast cancer for most women in a long-term study of around 10,000 women in the USA... [Read More]
05 August 2013 - by Rivka Marks-Maran 
Women who have fertility treatment to boost egg production are not at increased risk of death or developing major heart disease later in life, according to a Canadian study... [Read More]
09 July 2013 - by Siobhan Chan 
Children born as a result of assisted reproduction do not have a higher risk of developing cancer during childhood than those conceived spontaneously, according to a large UK study... [Read More]
25 February 2013 - by Dr Lucy Freem 
IVF treatment is not associated with an increase in breast, cervical or endometrial cancer, according to analysis of thousands of patient medical records. Ovarian cancer risk was also examined but too few people with ovarian cancer were included in the study for a conclusive result to be shown either way... [Read More]
10 September 2012 - by Daryl Ramai 
Women carrying mutations in their BRCA genes may be more susceptible to breast cancer if exposed to diagnostic chest X-rays before the age of 30, say scientists... [Read More]

30 April 2012 - by Dr Daniel Grimes 
French researchers have reported an association between drugs given to mothers undergoing fertility treatment and an increased risk of leukaemia in their children... [Read More]
31 October 2011 - by Sarah Guy 
Women who undergo IVF treatment have an increased risk of developing borderline, non-fatal ovarian tumours according to a clinical study from the Netherlands... [Read More]
06 December 2010 - by Rosemary Paxman 
A new study has shown that IVF may not be linked to an increased risk of certain cancers among female patients. A team of Swedish researchers concluded that although cancer or cancer treatment may increase the need for IVF, the risks of cancer post-IVF treatment were low... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation